Developing and Validating VR-Enabled Ophthalmic Clinics: A New Paradigm for Visual Function Testing

NCT ID: NCT04530773

Last Updated: 2025-06-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to design and validate a VR-based ophthalmic clinic that replicates traditional tests of visual acuity, stereopsis, and contrast sensitivity within an immersive digital environment. Using a rigorously developed system based onprogrammable interfaces, and standardized testing paradigms, we compared VR assessments against gold-standard clinical tools in a cohort of healthy adult participants. Key outcomes included test consistency, correlation, user acceptability, visual fatigue, and time efficiency. Our findings offer evidence for the viability of VR as a platform for remote ophthalmic testing and pave the way for scalable digital eye care delivery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Visual Health of Virtual Reality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GROUP1

Group Type EXPERIMENTAL

Watch VR movies/ Play VR games

Intervention Type BEHAVIORAL

The healthy individuals will watch VR movies or play VR games with different Physical parameters for 60 minutes.

GROUP2

Group Type EXPERIMENTAL

Watch VR movies/ Play VR games

Intervention Type BEHAVIORAL

The healthy individuals will watch VR movies or play VR games with different Physical parameters for 60 minutes.

GROUP3

Group Type EXPERIMENTAL

Watch VR movies/ Play VR games

Intervention Type BEHAVIORAL

The healthy individuals will watch VR movies or play VR games with different Physical parameters for 60 minutes.

GROUP4

Group Type EXPERIMENTAL

Watch VR movies/ Play VR games

Intervention Type BEHAVIORAL

The healthy individuals will watch VR movies or play VR games with different Physical parameters for 60 minutes.

GROUP5

Group Type EXPERIMENTAL

Watch VR movies/ Play VR games

Intervention Type BEHAVIORAL

The healthy individuals will watch VR movies or play VR games with different Physical parameters for 60 minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Watch VR movies/ Play VR games

The healthy individuals will watch VR movies or play VR games with different Physical parameters for 60 minutes.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The study included healthy individuals older than 18 years of age with a best-corrected visual acuity (BCVA) of \<0.1 logarithm of minimum angle of resolution (logMAR) and no ongoing or prior history of ocular or systemic disease.

Exclusion Criteria

* The study excluded healthy individuals younger than 18 years of age with a best-corrected visual acuity (BCVA) of \>0.1 logarithm of minimum angle of resolution (logMAR) with ongoing or prior history of ocular or systemic disease.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zhongshan Ophthalmic Center, Sun Yat-sen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jin Yuan

Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zhongshan Opthalmic Center

Guangzhou, Guangdong, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020KYPJ092

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

AR Training in Adults With Unilateral Amblyopia
NCT06704737 ACTIVE_NOT_RECRUITING NA
Shanghai Eye Study for Adults
NCT03455478 RECRUITING NA